Promethazine Dosing for Adults
For nausea and vomiting, administer promethazine 12.5-25 mg intravenously (infused slowly at ≤25 mg/min) or intramuscularly every 4-6 hours as needed, with a maximum daily dose of 100 mg when used as an adjuvant to other sedatives/analgesics. 1, 2, 3
Route-Specific Dosing
Nausea and Vomiting
Intravenous: 12.5-25 mg, infused slowly (≤25 mg/min) to minimize hypotension risk 1, 2
Intramuscular: 25-100 mg 1
- Preferred route per recent FDA guidance due to lower risk of tissue injury 4
- Can repeat every 4-6 hours
Oral: 12.5-25 mg every 4-6 hours 3
- For prophylaxis: 25 mg twice daily
- Maximum: 100 mg daily for antiemetic use
Allergic Reactions
- Oral: 25 mg at bedtime, or 12.5 mg before meals and at bedtime 3
- Alternative: 6.25-12.5 mg three times daily
- Single 25 mg dose controls minor transfusion reactions 3
Important context: Promethazine is NOT first-line for anaphylaxis—epinephrine is the only appropriate initial treatment. Antihistamines like promethazine are second-line adjuncts only. 5
Frequency and Maximum Doses
Clinical Pharmacology
Critical Safety Considerations
Black Box Warnings and Serious Risks
Tissue injury with IV administration: Risk of severe chemical irritation, tissue necrosis, and gangrene with extravasation or inadvertent intra-arterial injection 2, 4
Respiratory depression: Particularly when combined with opioids or benzodiazepines 1, 2
- Requires dose reduction of concomitant sedatives 1
Contraindicated in children <2 years due to fatal respiratory depression risk 3
Other Adverse Effects
- Hypotension (minimize by slow infusion) 1, 2
- Extrapyramidal effects (restlessness to oculogyric crises) 1, 2
- Neuroleptic malignant syndrome 1
- Sedation (dose-dependent; 6.25 mg causes less sedation than 12.5 mg) 7
Evidence-Based Efficacy
For nausea/vomiting: Recent systematic review and network meta-analysis found promethazine is "definitely among the most harmful" agents when considering adverse reactions, though it remains effective for symptom control 8. Low-dose promethazine (6.25 mg) provides equivalent antiemetic efficacy to 12.5 mg with significantly less sedation 7.
For allergic reactions: Promethazine showed NO efficacy in preventing anaphylactic reactions to antivenom in a randomized controlled trial (24% reaction rate vs 25% with placebo) 9. It should never be used as monotherapy for anaphylaxis 5.
Practical Algorithm for Use
First, consider alternatives: Ondansetron, metoclopramide, or prochlorperazine have superior safety profiles for nausea/vomiting 8
If promethazine selected:
Avoid in:
Contemporary practice note: Many institutions have removed injectable promethazine from formularies due to safety concerns, favoring agents with better risk-benefit profiles 10, 4. The continued routine use of injectable promethazine warrants critical reassessment given availability of safer alternatives 10.